Lexaria Bioscience Corp.
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
CHRISTOPHER RICHARD officer: Chief Executive Officer
 common shares 27,172 $2.47 $67,169
Purchase
CHRISTOPHER RICHARD officer: Chief Executive Officer
 common shares 22,828 $2.24 $51,226
Purchase
TURKEL CATHERINE C. director
 common shares 1,600 $3.13 $5,008
Sale
CARLE VANESSA officer: Secretary
 common shares 2,567 $4 $10,268
Option
CARLE VANESSA officer: Secretary
 Stock Options 2,500 $1.15 $2,875
Option
CARLE VANESSA officer: Secretary
 common shares 2,500 $1.15 $2,875
Purchase
TURKEL CATHERINE C. director
 Common Shares 1,500 $2.85 $4,268
Purchase
DOWNEY GREGORY officer: Chief Financial Officer
 common shares 121 $2.09 $253
Purchase
BUNKA CHRISTOPHER officer: Chief Executive Officer
 common shares 16,600 $2.1 $34,860
Purchase
BUNKA CHRISTOPHER officer: Chief Executive Officer
 common shares 21,900 $1.99 $43,537

Showing 1 to 10 of 10 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: